Fernán Agüero

8PUBLICATIONS
12CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 04, 2026
New hit compounds against Trypanosoma cruzi derived from mining yeast chemogenomic profiling data.

|Jan 02, 2026
Identification of Antifungal Agents AR-12 and Fosmanogepix as Anti-Trypanosoma cruzi Drugs through an Enhanced Fluorogenic β-Galactosidase Phenotypic Screening Assay.

Mercedes Didier Garnham, Franco Agustín Agüero, Juan Carlos Ramírez

|Aug 09, 2023
Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.

Guadalupe Romer, Leonel A Bracco, Alejandro D Ricci

|Apr 03, 2023
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas.

Alejandro D Ricci, Leonel Bracco, Emir Salas-Sarduy

|Feb 09, 2022
Characterization of ADAT2/3 molecules in Trypanosoma cruzi and regulation of mucin gene expression by tRNA editing.

Santiago Bertotti, Ian Fleming, María de Los Milagros Cámara

|Jun 06, 2018
Author Correction: Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes.

Emir Salas-Sarduy, Lionel Urán Landaburu, Joel Karpiak

Pageof 2

Frequent Collaborators

3 joint publications

Emir Salas-Sarduy

2 joint publications

Carlos A Buscaglia

2 joint publications

Mercedes Didier Garnham

1 joint publications

Santiago J Carmona